Related Experiment Videos
Applications of intravenous immunoglobulin
1Edinburgh and South East Scotland Blood Transfusion Service, UK.
The Malaysian Journal of Pathology
|June 1, 1990
Summary
Intravenous immunoglobulin (IV Ig) therapy offers rapid IgG administration for antibody deficiency and recurrent infections. High doses also treat non-immunodeficient conditions like idiopathic thrombocytopenic purpura, though duration and cost are limitations.
Area of Science:
- Immunology
- Pharmacology
Background:
- Intravenous immunoglobulin (IV Ig) preparations enable rapid IgG administration.
- Licensed IV IgG products have low adverse reaction rates.
- Manufacturing methods for IV IgG vary.
Purpose of the Study:
- To review the applications of IV IgG therapy.
- To discuss the benefits and limitations of IV IgG in various conditions.
Main Methods:
- Literature review of IV IgG preparations and their clinical uses.
Main Results:
- IV IgG is primarily used for IgG replacement in primary hypogammaglobulinaemia and antibody deficiency with recurrent infections.
- Patients with secondary hypogammaglobulinaemia, including those with hematological malignancies, can benefit.
- High-dose IV IgG is effective for non-immunodeficient conditions like idiopathic thrombocytopenic purpura.
Conclusions:
- IV IgG is a valuable therapeutic option for immunodeficiencies and certain autoimmune/hematological conditions.
- Limitations include short duration of action in autoimmune diseases and high cost for extensive use.